Clinical Trial Update: Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of sirolimus for maintenance treatment of Kaposiform Hemangioendothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: West China Hospital | Conditions: Hemangioendothelioma | Phase 2 | Status: UNKNOWN